| abstract |
The present invention relates to a process conducted on a processor or a machine learning processor for determining a specific dose of DHEA for a specific patient, by providing a dynamic predictive analysis using the biochemical parameters of the specific patient on the basis of his blood test or salivary test, his epigenetic molecular map, his medical parameters concerning the level of his depression, anxiety, quality of life and intensity of lack, and his psychological parameters. |